Account
Leo Burnett India wins creative mandate for Cholayil’s flagship brands
MUMBAI: Leo Burnett India has won the creative mandate for Cholayil’s flagship brands Medimix, Cuticura, and Krishna Thulasi for its entire existing product portfolio and future launches. The new business was won after a multi-agency pitch. Leo Burnett India’s Mumbai office will look after the brands.
Speaking about partnering Leo Burnett India, Cholayil Private Ltd CMD Pradeep Cholayil said, “Medimix is a heritage Ayurvedic brand which is turning 50 next year. The brand stands for its Ayurvedic goodness and efficacy and has a good connect with its users. We are very strong in the Western region with good footprints in a few north markets. The consumer today has realised the significance of Ayurveda and is slowly shifting from cosmetic products to natural products. We believe that it is the right time for us to expand our presence in the Northern and Eastern markets by leveraging this trend. Today, Medimix has become a global brand with a presence in close to 30 countries. We intend to increase our market share in our core markets and expand into new territories. Apart from expansion, we have plans of bringing in new products under the Medimix portfolio in both domestic and international markets.”
He further added, “Given this objective and our aggressive plans for the future, we had called for a pitch and ultimately chose to go with Leo Burnett India. We liked their creative approach, the quick understanding of the category and of the brand’s objective. Leo Burnett India not just brings its rich expertise of understanding various markets but also provides a young, fresh perspective to the brand. We believe they can partner us very well in our efforts to take Medimix to a new pedestal at a global level in the most effective and integrated way."
Cholayil Private Ltd marketing head Ashish Ohlyan said, “The personal care category in India is gradually moving towards Ayurvedic and natural products. We have a heritage brand with strong equity in Ayurveda and trust of 50 years. The growing penchant for natural and Ayurvedic products gives us an opportunity to expand our presence across markets. To connect well with consumers in new markets, we have a task of making our Ayurvedic offering relevant for all age groups. We also intend to enter new categories. I am confident that our association with Leo Burnett India is a key step towards taking the brand to new pinnacles with the right positioning and communication.”
Leo Burnett MD – India and chief strategy officer, South Asia Dheeraj Sinha said, “Medimix has very strong equity in personal care. India is witnessing a big revival of interest in Ayurveda and its solutions. With the equity of Medimix and the current megatrend in favour of our indigenous solutions, I am sure Medimix will gain further mind and market share. As the partner agency, we will be thinking of the brand narrative in a way that it keeps the brand contemporary and talks to its audience through various media choices available today.”
Added Leo Burnett India chief operating officer – west Rakesh Hinduja said, “We are keenly looking forward to partner the journey of this precious legacy brand. Medimix has strong equity in various pockets of India and our ambition is to create an unparalleled connect across India. With Leo Burnett’s innovation-oriented and culture context approach, backed by the Power of One, we aim to achieve leadership with newer category benchmarks and work for brand Medimix across the communications ecosystem.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
